8-KCorporate ChangesExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Bylaw Amendment (Feb 21, 2007)

Filed February 21, 2007For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences Corporation, dated February 21, 2007, primarily reports on an amendment to the company's Bylaws. The Board of Directors approved the authorization for the issuance of uncertificated shares, while continuing to permit the issuance of certificated shares. This change relates to the operational and administrative structure of the company's share management. For investors, this update is largely procedural and does not immediately impact the company's financial performance or strategic direction. It signifies a modernization of the company's corporate governance to allow for more efficient share tracking and transfer mechanisms, which is a common practice for publicly traded companies. No immediate financial implications or significant business events are detailed in this report.

Key Highlights

  • 1Edwards Lifesciences Corporation amended its Bylaws on February 15, 2007.
  • 2The amendment authorizes the issuance of uncertificated shares.
  • 3The Bylaws continue to allow for the issuance of certificated shares.
  • 4The filing is made under Item 5.03 of Form 8-K, pertaining to amendments to articles of incorporation or bylaws.
  • 5The filing includes the Amended and Restated Bylaws as an exhibit.
  • 6The report was filed with the SEC on February 20, 2007.

Frequently Asked Questions

The main purpose of this 8-K filing is to report an amendment to Edwards Lifesciences Corporation's Bylaws, which now authorizes the issuance of uncertificated shares.

For most current shareholders, this change is largely administrative. It allows for more modern and potentially efficient methods of share ownership and transfer, often through electronic book-entry systems, rather than relying solely on physical stock certificates.

No, this filing is purely a corporate governance update related to share issuance. It does not disclose any information about the company's financial performance, earnings, or strategic business decisions.

The Amended and Restated Bylaws of Edwards Lifesciences Corporation are attached as Exhibit 3.2 to this Form 8-K filing with the SEC.